GATA1 and acute megakaryoblastic leukemia: Therefore, it is crucial to perform GATA1 mutation analysis on each patient with pediatric AMKL and it may not be advisable that children with GATA1-mutations are stratified to the high-risk arm of AML protocols like other AMKL patients.